A day after the Serum Institute of India applied to the Indian authorities to conduct a small domestic trial of Novavax's coronavirus vaccine, SII chief Adar Poonawalla on Saturday said that the firm is hopeful of launching the Covid-19 vaccine by June this year, under the local brand Covovax. Poonawalla has said that SII's partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published 'excellent efficacy results'.

A day after the Serum Institute of India applied to the Indian authorities to conduct a small domestic trial of Novavax's coronavirus vaccine, SII chief Adar Poonawalla on Saturday said that the firm is hopeful of launching the Covid-19 vaccine by June this year, under the local brand Covovax. Poonawalla has said that SII's partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published 'excellent efficacy results'.